IGC Pharma, Inc. IGC
NYSE American · XASE · stock
IGC Pharma, Inc. institutional holders (13F)
| Investor | Shares | Value | % of company |
|---|---|---|---|
| BlackRock Finance, Inc. | 703,798 | $305,308 | 0.87% |
| RENAISSANCE TECHNOLOGIES LLC | 483,975 | $127,285 | 0.6% |
% of company = reported 13F shares ÷ shares outstanding. Based on the latest filings; not every holder reports every quarter.
Source: SEC EDGAR filings · CIK 0001326205 · US · as of 2025-03-31. facts plus Stocktoria's own computed scores — not investment advice.